LGND EBITDA Margin
Ligand Pharmaceuticals Inc · EBITDA Margin
LGND EBITDA Margin
Latest reported94.32%period ending
LGND EBITDA Margin (-138.35% → 94.32%)
Annual ebitda margin
High-resolution chart · PNG
LGND ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 71.8927% | |
| 24.4081% | |
| 76.7907% | |
| 41.3789% | |
| 59.1072% | |
| 34.6492% | |
| 728.3841% | |
| 93.9834% | |
| 56.9411% | |
| 50.6318% | |
| 41.6553% | |
| 36.2066% | |
| 38.0733% | |
| 12.5589% | |
| 5.7929% | |
| -55.7949% | |
| -16.6102% | |
| -352.4108% | |
| -388.5993% | |
| -43.8869% | |
| -14.9886% | |
| -11.1729% | |
| -42.2906% | |
| -36.3524% | |
| -21.6974% | |
| -80.3097% | |
| -132.5012% | |
| -367.7966% | |
| -40.619% | |
| -63.8587% | |
| -86.5306% | |
| -138.3459% |